GSK plc GSK Cash Flow Statement (2009-2026)

NYSE GSK
$47.83 -0.75 (-1.54%)
At close: Nov 19, 2026 · 4:00 PM EST
Reported Financials

Gsk Quarterly Cash Flow Statement

Periods 51 quarters
Latest Sep 2026
Industry Template General

Gsk cash flow statement data for the quarter ended Sep 2026. This cash flow statement covers 51 quarters of results from Sep 2009 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2009 Dec2009 Sep2010 Dec2010 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Jun2017 Sep2017 Dec2017 Jun2018 Sep2018 Dec2018 Sep2019 Dec2019 Sep2020 Dec2020 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Sep2023 Dec2023 Mar2024 Sep2024 Dec2024 Sep2025 Dec2025 Jun2026 Sep2026
Operating Activities
Net Income
2,116.26M1,950.44M1,107.86M9,353.85M233.48M1,105.68M12,776.64M25,100.67M1,982.50M493.98M1,371.27M643.03M-2,851.88M207.96M
Depreciation and DepletionDep. & Depletion
Depreciation, Depletion & Amortization
Amortization of IntangiblesAmort. of Intangibles
Depreciation & Amortization (CF)Dep. & Amort.
632.66M673.72M1,259.71M582.34M560.89M8.21M777.93M1,462.08M696.42M1,085.84M1,407.32M
Share-based CompensationStock Comp.
Deferred Taxes
Cash from Discontinued OperationsCash from Discont. Ops
745.45M540.76M-186.50M
Gains from Equity InvestmentsGains Equity
-20.97M-5.14M51.50M1.22M12.41M
Gains from Investment SecuritiesGains Investment
-41.79M-331.94M-132.80M
Asset Writedowns and ImpairmentWritedown
Other non-cash itemsOther Non-Cash
262.68M-118.29M-178.26M-403.06M265.68M-1,128.36M211.50M-588.31M169.98M-182.26M-192.87M
Non-cash ItemsNon-Cash Items
Change in Working Capital
-600.59M2,581.74M2,065.19M947.65M-642.74M860.93M-1,021.03M1,782.29M-394.51M1,917.55M1,026.89M
Change in ReceivablesChange Receivables
-1,051.45M-185.32M-985.47M
Change in InventoryChange Inventory
-315.52M-526.25M
Change in Account PayablesChange Payables
-18.62M
Change in Other Operating AssetsOther Assets Change
-514.94M-537.20M
Change in Other Operating LiabilitiesOther Liabilities Change
-390.85M409.26M-1,586.24M961.89M-375.48M-178.41M-375.11M
Other Working Capital ChangesOther WC Changes
-390.85M514.94M409.26M537.20M-1,586.24M961.89M-375.48M-178.41M-375.11M
Other Operating Activities (as filed)
22.45M12.41M
Cash from OperationsCash from Ops.
3,101.63M4,439.61M5,090.34M5,435.18M2,960.09M3,131.72M348.85M2,920.43M1,428.35M1,641.60M-3,352.02M
Investing Activities
Capital ExpendituresCapex
-350.24M2,635.74M2,246.09M2,057.06M-258.97M2,167.57M-283.21M2,658.55M-314.59M2,893.01M413.68M
Sales of Property, Plant and EquipmentPP&E (Sale)
19.73M11.57M18.49M18.87M8.05M156.00M8.51M8.69M1.27M78.29M-6.65M
Change in Property, Plant and EquipmentChange in PP&E
369.98M-2,624.16M-2,227.60M-2,038.19M267.03M-2,011.57M291.72M-2,649.86M315.86M-2,814.72M-420.33M
Change in IntangiblesChange Intangibless
-215.82M1,942.73M2,162.90M4,360.81M-505.87M2,248.50M-359.79M2,188.15M-399.58M3,305.02M755.53M
Acquisitions
114.69M9,153.08M7,199.43M3,619.20M-912.06M1,993.28M1,137.29M
Divestments
-17.27M136.29M-154.49M10.78M1.34M-28.15M-7.29M-8.69M-3.81M-6.42M-1.33M
Net of Acquisitions & DivestmentsNet Acquisitions
-131.96M-9,016.79M-154.49M10.78M1.34M-7,227.58M-7.29M-3,627.89M908.26M-1,999.70M-1,138.62M
Purchase of InvestmentsInvestments Purchased
-234.32M639.01M1,065.60M415.19M-60.38M310.83M-68.07M266.85M-22.83M284.94M9.31M
Sale and Maturity of InvestmentsInvestments Sold
14.80M23.14M178.26M-48.53M144.27M12.16M1,239.91M1,338.29M2.57M-159.62M
Change in Acquisitions & DivestmentsChange Acquisitions
-1.29M1.32M-24.26M-1.17M-89.36M27.91M-26.95M-14.63M
Other Investing Activities (as filed)Other investing (as filed)
93.73M375.43M594.20M94.36M6.71M-4,282.36M4.86M156.39M34.25M202.79M-47.89M
Cash from Investing ActivitiesCash from Investing
-6,083.64M-475.72M-68.66M-2,283.53M-4,821.22M-633.38M-495.93M332.63M-189.01M-1,436.24M2,036.48M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
2,736.59M-36.00M-4,354.85M1.35M12,351.60M1,191.70M-175.03M-276.78M-1,379.76M
Long-Term Debt RepaymentsLT Debt Repayment
-334.12M6,867.50M670.96M1,074.84M-409.73M3,082.97M-9.31M
Net Long-Term Debt Issued (Repaid)Net LT Debt
2,736.59M-36.00M-4,354.85M1.35M12,685.71M-5,675.80M-845.99M-1,351.61M409.73M-4,462.74M9.31M
Short-Term Debt repaymentsST Debt Repayment
-8.63M10,816.80M12,626.15M3,884.97M11,839.54M539.90M
Net Short-Term Debt Issued (Repaid)Net ST Debt
-3,582.60M1,369.30M9,645.89M2,689.28M334.12M-3,736.95M-670.96M-539.90M-409.73M1,040.92M-1,443.23M
Net Debt Issuances and RepaymentsNet Debt Issuance
717.75M-2,945.60M5,856.20M1,269.83M653.47M-9,412.75M-915.28M2,677.16M100.21M2,496.41M-1,806.37M
Change in Capital Stock
Common Stock IssuedStock Issued
9.87M12.86M1.32M1.35M22.81M9.72M1.24M22.83M
Shares Repurchased
-2,462.59M421.66M
Net Shares Issued and RepurchasedNet Shares Issued
9.87M12.86M1.32M1.35M22.81M9.72M1.24M22.83M2,462.59M-421.66M
Net Equity Issued and RepurchasedNet Equity Issued
9.87M12.86M1.32M1.35M22.81M9.72M1.24M22.83M2,462.59M-421.66M
Dividend Payments
Dividends Paid - Common and PreferredDiv Paid (Total)
-1,159.26M8,955.07M9,253.72M9,499.43M-1,277.43M7,365.99M-674.61M4,872.76M-720.52M5,488.25M864.61M
Other financing activities (as filed)
-67.83M-788.15M299.74M289.82M12,446.87M213.47M-57.13M244.51M-72.31M290.07M74.49M
Cash from Financing ActivitiesCash from Financing
-4,300.36M-3,547.32M-2,871.98M-4,164.00M-1,748.41M-1,569.38M-386.53M-4,458.22M-1,344.63M-1,080.71M1,749.17M
Additional items
Exchange Rate EffectFX Effect
7.40M-131.14M-178.26M423.28M16.10M2,965.16M-37.68M687.60M-24.10M150.17M-78.48M
Change in Cash
416.57M2,149.69M-1,906.09M9,288.19M-8,910.74M-818.04M-580.86M-318.40M472.33M-235.44M
Beginning Cash Balance
4,591.88M4,526.56M4,366.41M
Ending Cash Balance
5,292.21M6,334.91M5,510.74M7,172.45M4,636.14M5,155.03M14,409.41M-22,157.94M4,129.29M3,579.92M3,877.46M3,639.37M3,522.73M4,271.95M4,270.46M4,428.92M4,318.93M3,882.49M
Free Cash FlowFCF
3,451.88M1,803.87M2,844.25M3,378.11M3,219.06M964.15M632.06M261.88M1,742.94M-1,251.41M-3,765.70M
Net Cash FlowNCF
-7,282.36M416.57M2,149.69M-1,012.36M-3,609.54M928.96M-533.61M-1,205.16M-105.29M-875.35M433.63M
Interest Paid
-110.99M1,843.73M1,806.38M1,679.62M-110.03M1,585.80M-145.86M1,546.48M-90.06M1,305.32M78.48M
Income Taxes PaidTaxes Paid
-277.48M3,305.60M3,949.47M103.80M-195.91M2,838.49M-284.43M2,694.54M-213.11M3,025.21M396.39M

Gsk Cash Flow Statement API

Pull Gsk's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GSK&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY